Immunomic Therapeutics

United States
Williston Park, New York, United States, 17603

Company profile

Immunomic Therapeutics company profile

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines for the treatment of allergy and other human health targets. The company was founded in 2005 and is based in Lancaster, Pennsylvania.

Business identity

Contact email
[email protected]
Phone number
717-327-1919
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
17603
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
10
Total equity funding
$84.9M
Last funding
Series Unknown / $6.5M / 2025-06-02
Last equity funding
Series Unknown / $6.5M
Investors
5
Lead investors
1
Founders
2
Articles
64

Founders and investors

Founders

Teri HeilandWilliam G. Hearl

Lead investors

Mid Atlantic Bio Angels

Investors

Brainchild HoldingsKeiretsu Forum NorthwestLife Sciences Greenhouse of PennsylvaniaMid Atlantic Bio AngelsMinority Angel Investor Network